Amesite Operating Co Stock price
$0.55
-0.29
34.36%
1M
-0.24
30.44%
6M
-1.34
71.07%
YTD
-2.04
78.89%
1Y
-1.62
74.80%
3Y
-15.89
96.67%
5Y
-62.09
99.13%
10Y
-62.09
99.13%
20Y
Nasdaq,
Closing price Mon, Nov 16 2026
+0.07
15.12%
Powered by
ISIN
US0310941051
Symbol
AMST
Index
Sector
Industry
Is Amesite Operating Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.
Key metrics
Basic
Market capitalization
$3.6m
Enterprise Value
$1.3m
Net debt
positive
Cash
$2.3m
Shares outstanding
6.6m
Valuation
P/E
negative
P/S | estimate
9.9 | -
EV/Sales | estimate
3.6 | -
EV/FCF | ex SBC
negative | negative
P/B
1.4
Financial Health
Equity Ratio
87.6%
Return on Equity
-116.7%
ROCE
-118.6%
ROIC
-
Debt/Equity
0.0
Amesite Operating Co Stock Analysis
Unlock Scores for Free
Analyst Opinions
7 Analysts have issued a Amesite Operating Co forecast:
Analyst Opinions
7 Analysts have issued a Amesite Operating Co forecast:
Buy
86%
Hold
14%
Don't miss a Thing! We will send you all news about Amesite Operating Co directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Amesite Operating Co Stock News
Neutral
GlobeNewsWire
●
one day ago
Amesite announces its latest major enterprise win, increasing its revenue and deploying AI automations for another large healthcare organization in just days on its secure, AI-native infrastructure Amesite announces its latest major enterprise win, increasing its revenue and deploying AI automations for another large healthcare organization in just days on its secure, AI-native infrastructure
Neutral
GlobeNewsWire
●
about 2 months ago
Company Estimates Agreements at New Pricing Level Can Generate Approximately 85% Gross Margin, Supporting Scalable Growth Across Post-Acute Care Organizations Company Estimates Agreements at New Pricing Level Can Generate Approximately 85% Gross Margin, Supporting Scalable Growth Across Post-Acute Care Organizations
Neutral
GlobeNewsWire
●
6 months ago
Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care
Company Profile
Amesite, Inc. is a development stage artificial intelligence software company. The company is headquartered in Detroit, MI.
| Head office | United States |
| CEO | Dr. Sastry |
| Employees | 6 |
| Founded | 2017 |
| Website | amesite.com |


